Skip to main content
Livermore
Livermore
ZHEN

Kiniksa Pharmaceuticals International, plc

KNSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001730430

In the last 90 days, Kiniksa Pharmaceuticals International, plc insiders filed 0 open-market purchases and 2 sales; 267 institutions reported holding it in 13F filings for Q2 2026, worth $2.99B in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Kiniksa Pharmaceuticals International, plc changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of KNSA: Q4 2024 compared with Q1 2025
MeasureQ4 2024Of which not filed for Q1 2025Q1 2025Change
Holders1602176+18
Shares39.1M795.6K40.0M+1.76M (+4.6%)
Value$773.1M$15.7M$889.4M+$132.0M (+17.4%)

2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (36)

Institutions that held Kiniksa Pharmaceuticals International, plc at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to KNSA in Q1 2025
InstitutionSharesValue% of portfolio
Point72 Asset Management, L.P.1,149,411$25.5M0.07%
Nuveen, LLC765,054$17.0M0.01%
Soleus Capital Management, L.P.469,500$10.4M0.82%
Cubist Systematic Strategies, LLC209,939$4.66M0.06%
Kodai Capital Management LP185,364$4.12M0.16%
Vestal Point Capital, LP169,864$3.77M0.27%
Susquehanna Fundamental Investments, LLC97,992$2.18M0.04%
Silverarc Capital Management, LLC88,215$1.96M0.41%
Walleye Capital LLC86,203$1.91M0.02%
Opaleye Management Inc.62,501$1.39M0.31%
Victory Capital Management Inc53,317$1.18M0.00%
Ieq Capital, LLC43,625$968.9K0.01%
Campbell & CO Investment Adviser LLC22,036$489.4K0.04%
Fred Alger Management, LLC21,823$484.7K0.00%
Tudor Investment Corp Et Al20,621$458.0K0.00%
Virtus Investment Advisers, Inc.17,828$396.0K0.11%
Amundi15,972$347.6K0.00%
Dark Forest Capital Management LP14,108$313.3K0.01%
Wealth Enhancement Advisory Services, LLC13,564$301.3K0.00%
BIT Capital GmbH11,878$263.8K0.03%
Mariner, LLC11,441$254.1K0.00%
Fox Run Management, L.L.C.11,352$252.1K0.04%
Polymer Capital Management (US) LLC9,142$203.0K0.06%
State Board of Administration of Florida Retirement System9,127$202.7K0.00%
Man Group plc9,121$202.6K0.00%
Asset Management One Co.,Ltd.1,860$41.3K0.00%
US Bancorp1,473$32.7K0.00%
Aster Capital Management (DIFC) Ltd1,456$29.5K0.01%
Point72 (DIFC) Ltd923$20.5K0.00%
Group One Trading, L.P.808$17.9K0.00%
Coldstream Capital Management Inc496$11.0K0.00%
South State Corp.179$3.98K0.00%
Skopos Labs, Inc.141$3.13K0.00%
TD Waterhouse Canada Inc.100$2.17K0.00%
Larson Financial Group LLC33$7330.00%
Hughes Financial Services, LLC24$5220.00%

Sold out (18)

Institutions that held Kiniksa Pharmaceuticals International, plc at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of KNSA in Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse)1,582,635$31.3M
Jefferies Financial Group Inc.112,400$2.22M
Marshall Wace, LLP86,762$1.72M
M&T Bank Corp30,735$607.9K
Arrowstreet Capital, Limited Partnership22,453$444.1K
Woodline Partners LP19,005$375.9K
Virtus ETF Advisers LLC17,361$343.4K
Jump Financial, LLC14,601$288.8K
Y-Intercept (Hong Kong) Ltd13,050$258.1K
HRT Financial LP11,668$230.0K
Bellevue Group AG8,100$160.2K
Advisor Group Holdings, Inc.618$12.2K
National Bank of Canada494$9.77K
Brown Brothers Harriman & Co333$6.59K
Smartleaf Asset Management LLC214$4.19K
Creekmur Asset Management LLC95$1.88K
Van Hulzen Asset Management, LLC50$989
SRS Capital Advisors, Inc.1$20

Not filed for Q1 2025 yet (2)

Institutions that held Kiniksa Pharmaceuticals International, plc at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding KNSA in Q4 2024 that haven't filed for Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Nuveen Asset Management, LLC795,612$15.7M
Cassady Schiller Wealth Management, LLC37$732